Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Neuropharmacology
|
April 5, 2021
The administration of sertraline plus naltrexone reduces ethanol consumption and motivation in a long-lasting animal model of post-traumatic stress disorder
Ani Gasparyan, Francisco Navarrete, Jorge Manzanares
Frontiers in Pharmacology
|
July 15, 2021
Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
Ani Gasparyan, Francisco Navarrete, Jorge Manzanares
Addiction Biology
|
March 1, 2022
CBD-mediated regulation of heroin withdrawal-induced behavioural and molecular changes in mice
Francisco Navarrete, Ani Gasparyan, Jorge Manzanares
Neuropharmacology
|
August 16, 2022
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies
Ani Gasparyan, Daniela Navarro, Francisco Navarrete, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and Lactation
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
Neuropharmacology
|
April 21, 2023
Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawal
Ani Gasparyan, Francisco Navarrete, Daniela Navarro, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 24, 2020
Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal
Ani Gasparyan, Francisco Navarrete, Marta Rodríguez-Arias, et al.
Biomolecules
|
November 27, 2021
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
Francisco Navarrete, María S García-Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology
|
June 7, 2021
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María Salud García-Gutiérrez, Ani Gasparyan, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 23, 2022
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares, María Salud García-Gutiérrez, Lucía Illescas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Neuropharmacology
|
April 5, 2021
The administration of sertraline plus naltrexone reduces ethanol consumption and motivation in a long-lasting animal model of post-traumatic stress disorder
Ani Gasparyan, Francisco Navarrete, Jorge Manzanares
Frontiers in Pharmacology
|
July 15, 2021
Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
Ani Gasparyan, Francisco Navarrete, Jorge Manzanares
Addiction Biology
|
March 1, 2022
CBD-mediated regulation of heroin withdrawal-induced behavioural and molecular changes in mice
Francisco Navarrete, Ani Gasparyan, Jorge Manzanares
Neuropharmacology
|
August 16, 2022
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies
Ani Gasparyan, Daniela Navarro, Francisco Navarrete, et al.
International Journal of Molecular Sciences
|
July 13, 2024
Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and Lactation
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
Neuropharmacology
|
April 21, 2023
Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawal
Ani Gasparyan, Francisco Navarrete, Daniela Navarro, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 24, 2020
Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal
Ani Gasparyan, Francisco Navarrete, Marta Rodríguez-Arias, et al.
Biomolecules
|
November 27, 2021
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
Francisco Navarrete, María S García-Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology
|
June 7, 2021
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María Salud García-Gutiérrez, Ani Gasparyan, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 23, 2022
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares, María Salud García-Gutiérrez, Lucía Illescas, et al.
Page
of 3